ACHC Company Profile and Key Details

ACHC has shown mixed momentum, gaining 7.63% over the past week and -41.07% over the past quarter, though year-to-date performance is up 0.35%. Short-term trend indicators are mixed aligned (SMA20 42.09%, SMA50 52.06%, SMA200 12.07%). The stock’s 14-day RSI is 83.33 (overbought), while the ATR of 1.21 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -47.98% below its high and over 95.01% above its low. Average 10-day trading volume of 1.10 million shares is below the 3-month average of 2.57 million, indicating normal recent market interest.

Acadia Healthcare Company, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $46.67. This means the shares are trading below this model’s fair value.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) closed at $28.36 USD, losing -$0.17 (-0.60%) from the previous close of $28.53. The stock is currently mid-range between its 52-week high and low $11.43 and $35.83. With a market capitalization of about $2.64 billion, Acadia Healthcare Company, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.62). Key stats such as the average daily volume over the past year has been around 2.61 million shares, volume is running light vs its 52-week average. Headquartered in Franklin, TN, Acadia Healthcare Company, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Debra K. Osteen, the company employs approximately 25,000 people and listed since March 04, 1994. Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico.

Wall Street analysts project EPS growth of -2.39% annually over the next five years. The latest quarter delivered EPS of $0.38. The next quarter is forecast at $0.26. Next year's EPS is expected at $9.93. Analyst sentiment is bullish. Analyst rating data shows there are 10 Strong Buy ratings, 16 Buy ratings, 13 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $40.00 to $15.00. The high target offers 41.04% upside. The low target suggests -47.11% downside. The mean target is $27.26. This offers -3.88% upside. Acadia Healthcare Company, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended July 28, 2026, missed forecasts by 9.73%. The prior quarter beat by 32.14%. Over the last six quarters, Apple has recorded several small beats. These include 14.29% in May 12, 2025.

Acadia Healthcare Company, Inc. has 93.10 million shares outstanding. The public float is 91.53 million shares, elevated short interest at 37.26% of float. This equals 22.58 million shares. The short ratio is 12.67 days. Institutional investors hold 148.66% of the float. Insiders own 1.54%. WAUD CAPITAL PARTNERS II, L.L.C. holds 3.87 million shares, WAUD CAPITAL PARTNERS III, L.L.C. has 1.84 million shares and OSTEEN DEBRA K has 675.83 thousand shares.

Acadia Healthcare Company, Inc. trades at a P/E ratio of -2.28, slightly below the S&P 500 average, with a price-to-sales ratio of 0.78 and a price-to-book ratio of 1.3 suggesting the stock is closer to book value. The P/FCF stands at -139.6, also below market averages.

Our AI price prediction model suggests that Acadia Healthcare Company, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -3.03%, with price expected at $27.50 by September 25, 2026, within a range of $25.61 to $29.33 3-Month Outlook: Projected fall of -70.1%, reaching $8.48 by December 10, 2026, with a range of $6.43 to $9.29. 1-Year Outlook: Projected loss of -99.96%, with price at $0.01 by September 10, 2027, within a range of $0.00 to $4.21.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares are flat 0.35% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Acadia Healthcare Company, Inc. trading at a premium to the broader market with a P/E of -2.28. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $53.53, suggesting 88.75% upside. Our AI forecast model points to short-term weakness (-3.03% over two weeks), a medium-term fall (-70.1% over three months), and a longer-term loss (-99.96% over one year), with expected trading ranges indicating moderate volatility.